Pila Pharma Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
PILA
- Investments
-
2
- Share Price
-
$0.44
- (As of Friday Closing)
Pila Pharma General Information
Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Contact Information
Website
www.pilapharma.comCorporate Office
- Norra Vallgatan 72
- Malmo
- Sweden
Corporate Office
- Norra Vallgatan 72
- Malmo
- Sweden
Pila Pharma Stock Performance
As of 08-Nov-2024, Pila Pharma’s stock price is $0.44. Its current market cap is $12M with 27.1M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.44 | $0.43 | $0.09 - $0.88 | $12M | 27.1M | 76.9K | -$0.02 |
Pila Pharma Financials Summary
As of 30-Jun-2024, Pila Pharma has a trailing 12-month revenue of $97.1K.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 9,024 | 3,842 | 4,984 | 8,371 |
Revenue | 97 | 138 | 185 | 84 |
EBITDA | (545) | (829) | (2,638) | (1,998) |
Net Income | (650) | (934) | (2,639) | (2,004) |
Total Assets | 422 | 846 | 1,044 | 3,515 |
Total Debt | 0 | 0 | 0 | 0 |
Pila Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Pila Pharma Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Pila Pharma Comparisons
Industry
Financing
Details
Pila Pharma Competitors (13)
One of Pila Pharma’s 13 competitors is AbbVie, a Corporation company based in North Chicago, IL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AbbVie | Corporation | North Chicago, IL | ||||
Roche | Corporation | Basel, Switzerland | ||||
TRPV Pharmaceuticals | Corporation | Stuart, FL | ||||
Eli Lilly and Company | Corporation | Indianapolis, IN | ||||
Amgen | Formerly PE-Backed | Thousand Oaks, CA |
Pila Pharma Patents
Pila Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2487238-A1 | Hydroxy tetrahydro-naphthalenylurea derivatives | Active | 08-May-2002 | ||
US-20060258742-A1 | Such as n-[4-chloro-3-(trifluoromethyl)phenyl]-n'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, copd | Active | 08-May-2002 | ||
US-7612113-B2 | Such as n-[4-chloro-3-(trifluoromethyl)phenyl]-n'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, copd | Active | 08-May-2002 | ||
CA-2487238-C | Hydroxy tetrahydro-naphthalenylurea derivatives | Inactive | 08-May-2002 | ||
AU-2003229734-A1 | Hydroxy tetrahydro-naphthalenylurea derivatives | Active | 08-May-2002 | C07C275/42 |
Pila Pharma Signals
Pila Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Pila Pharma Investments (2)
Pila Pharma’s most recent deal was a Later Stage VC with Dilafor for . The deal was made on 27-Sep-2016.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Dilafor | 27-Sep-2016 | Later Stage VC | Drug Discovery | ||
Ario Pharma (TRPV1 Antagonist Molecule) | 30-Mar-2016 | Corporate Asset Purchase | Buildings and Property |
Pila Pharma FAQs
-
When was Pila Pharma founded?
Pila Pharma was founded in 2014.
-
Where is Pila Pharma headquartered?
Pila Pharma is headquartered in Malmo, Sweden.
-
What is the size of Pila Pharma?
Pila Pharma has 3 total employees.
-
What industry is Pila Pharma in?
Pila Pharma’s primary industry is Drug Discovery.
-
Is Pila Pharma a private or public company?
Pila Pharma is a Public company.
-
What is Pila Pharma’s stock symbol?
The ticker symbol for Pila Pharma is PILA.
-
What is the current stock price of Pila Pharma?
As of 08-Nov-2024 the stock price of Pila Pharma is $0.44.
-
What is the current market cap of Pila Pharma?
The current market capitalization of Pila Pharma is $12M.
-
What is Pila Pharma’s current revenue?
The trailing twelve month revenue for Pila Pharma is $97.1K.
-
Who are Pila Pharma’s competitors?
AbbVie, Roche, TRPV Pharmaceuticals, Eli Lilly and Company, and Amgen are some of the 13 competitors of Pila Pharma.
-
What is Pila Pharma’s annual earnings per share (EPS)?
Pila Pharma’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »